Defining the Value of Medical Interventions

Name: Defining the Value of Medical Interventions | Normative and Empirical Challenges
Brand: Kohlhammer
Price: 25.99 EUR
Availability: OnlineOnly

Normative and Empirical Challenges

Jan Schildmann Charlotte Buch Jürgen Zerth(Herausgeber*in)

Kohlhammer (Verlag)

1. Auflage

Erschienen am 10. Februar 2021

176 Seiten

E-Book

PDF mit Wasserzeichen-DRM

Systemvoraussetzungen

978-3-17-038177-3 (ISBN)

25,99 €inkl. 7% MwSt.

Systemvoraussetzungen

für PDF mit Wasserzeichen-DRM

E-Book Einzellizenz

Als Download verfügbar

Beschreibung

Weitere Details

Weitere Ausgaben

Personen

Inhalt

Cover sheet
Front page
Imprint
Table of contents
Defining the value of medical interventions - a brief introduction
The Scientific Conference
The contributions
1. Value(s) in healthcare. Introduction and theoretical premises
2. Value in healthcare. Interdisciplinary analyses
3. Including values and preferences by patients in healthcare. Methods and case studies
The concepts of 'health' and 'disease'
Abstract
1 Introduction: building the bridge between the concepts of 'health' and 'disease' and the of idea value in medical interventions
2 The complexities behind conceptualising health: Its operationalisation and the goals of medicine
3 The complexities behind conceptualising disease: what can we learn from key definitions?
4 Conclusion: embracing complexity
References
Ethical conceptualization of a sustainable right to health(care)
Abstract
1 Outline of the argument
2 From the value of health follows a universal right to health and to healthcare
2.1 Objectivity of values (cf. Nagel, 1986)
2.2 Definition of the right to health as encompassing socioeconomic, environmental, and other rights and a right to healthcare (cf. ICESCR, 1966)
2.3 Refutation of arguments against a universal right to healthcare
2.4 Agent-neutral and agent-relative right to health(care) (cf. Nagel, 1986)
3 From the universal right to health(care) follows a sustainable right to health(care)
3.1 Traditional concept of sustainability (cf. WCED, 1987
Elkington, 1999
MacDonald and Norman, 2007)
3.2 The concept of a sustainable right to health
3.3 The concept of a sustainable right to healthcare
4 Discussion of the economic aspects of the right to healthcare in consideration of a possible conflict between agent-relative and agent-neutral rights
4.1 Selected aspects of the debate on healthcare rationing indifferent countries
4.2 Inability to pay as a possible restriction to the right to healthcare?
4.3 Disregard for agent-relative rights to healthcare in Porter's economic definition of the value of healthcare (cf. DeCamp, 2019
Porter, 2010)
5 Limitations and implications
References
Value(s) in healthcare. Interdisciplinary analyses
The cost-effectiveness of what in health and care?
Abstract
1 Introduction
2 Economic evaluation in health and care: the rationale
3 Health economic evaluation: key steps
3.1 Defining evaluation perspective
3.2 Generating QALYs
3.3 Using QALYs to aid decision-making
4 An alternative to QALYs based on the Capability Approach
4.1 Capability measures
4.2 Measuring and valuing capabilities
4.3 Using capability measures to aid decision-making
5 Summary
References
The assessment of value in health economics: utility and capability
Abstract
1 Introduction
2 The informational base in conventional health economics
3 Broadening the informational base with the capability approach
3.1 Amartya Sen and the capability approach
3.2 The advantages of using capability over utility
4 The need to integrate utility and the capability approach
5 Conclusion
References
Estimating the monetary value of health: why and how
Abstract
1 Introduction
2 Ethics of cost-effectiveness and its decision rule
3 Previous approaches for estimating the monetary value of a QALY
4 The well-being valuation approach
5 Applications of the well-being valuation approach
5.1 The value of a QALY and a year in full capability in the UK
5.2 The value of a QALY in Germany
6 Concluding remarks
References
Risk-sharing schemes to finance expensive pharmaceuticals
Abstract
1 Introduction
2 Challenges of expensive pharmaceuticals - the impact of a risk-based regulation scheme
2.1 Risk-sharing within a value-based regulation approach
2.2 Financial-based risk-sharing agreements
2.3 Performance-based risk-sharing agreements
3 Case example: The multiple sclerosis risk-sharing scheme in the UK
4 Discussion
4.1 Strengths of PBRSA (in the context of the MS risk-sharing scheme)
4.2 Weaknesses (in the context of the MS risk-sharing scheme)
5 Conclusion
References
Including values and preferences by patients in healthcare. Methods and case studies
Integrating patients and social aspects into health technology assessment
Abstract
1 Valuation of health technologies
1.1 What is health technology assessment?
1.2 Recommended domains for a health technology assessment
1.3 The HTA Core Model® domain "Patients and Social aspects (SOC)"
2. Why include patients and social aspects
2.1 The purpose of integrating patients and social aspects
2.2 Relevant outcomes for the patients and social aspects domain
3 How to include patients and social aspects
3.1 Current state of including patients and social aspects
3.2 Gathering information
3.3 Quality assessment of the studies included
3.4 Analysing data on patients and social aspects
4 Example: secondary data analysis on patients and social aspects in an HTA on mistletoe therapy in breast cancer patients
4.1 Methods
4.2 Brief preliminary results
4.3 Discussion and challenges
References
The shared decision-making model and practical discourse to foster the appreciation of patients' value preferences in Polish healthcare
Abstract
1 Objectives
2 Methods
3 Background
4 Polish healthcare as an institution after the 1989 democratic turn
5 Ethical essentials of SDM with relations to discource ethics
6 When A, then B? From shared decisions to shared responsibilities
7 The appreciation of health and medical values in comparison to SDM in comparison to practical discourse
8 How can SDM and practical discourse models be implemented? Sampling cases
9 SDM meets Polish healtcare system: open questions
10 Conclusions and further research perspectives
References
Death or dialysis: the value of burdensome life-extending treatments for the cognitively impaired
Abstract
1 Introduction
2 Quality of life
3 Bridge therapy
4 Is dialysis worth it?
5 Conclusion
References
Contributors

Systemvoraussetzungen

Als PDF speichern Als Link merken